- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03075475
Effectiveness Study of a Treatment to Improve the Mental Health of Children and Adolescents
Study of Effectiveness of a Treatment to Improve the Mental Health of Children and Adolescents Affected by Armed Conflict in Kachin State, Myanmar
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Common Elements Treatment Approach (CETA) is a trans-diagnostic psychotherapeutic intervention.
Results from qualitative interviews following the randomized controlled trial (RCT) of CETA for adults (IRB # 00003601) and during the scale-up of CETA services have indicated that there is a major need for mental health services for children and adolescents in Myanmar, as currently there are no evidence-based psychotherapy services for children and adolescents in the country. Specifically, since the initial trial the research team has received requests from community-based organizations to implement CETA for children and adolescents in Kachin language-speaking communities in northern Myanmar. Local partners and the Applied Mental Health Research group (AMHR) at Johns Hopkins University (JHU) believe that CETA is amenable for use with children and adolescents and that this population would benefit in similar ways to adults. A qualitative study has since been conducted (IRB# 00006933), and the data used to develop and validate an assessment instrument with children and adolescents in Kachin state (IRB# 00006929).
The JHU research team will work with the local partner organization, Kachin Baptist Convention (KBC), to implement this project. KBC is a well-established community-based organization that currently provides emergency relief services to approximately 20,000 displaced Kachin people living in 42 camps. Their community outreach activities are non-denominational.
Participants will mostly be accessed through schools and in partnership with the local implementing partner. Their teachers, secondary caregivers and persons from the local partner organization who work with them regularly - all of whom are involved in the study as key community informants - will identify and refer the potential child/adolescent participants for screening into the study. Screening will otherwise be open to all children/adolescents, and those who are eligible will be asked to participate in the trial. Informed consent will be obtained from the parent/guardian and informed assent from the child. Participants will be randomly assigned to either receive CETA immediately or be put on a waitlist to receive treatment later.
Counselors will be current employees of the local partner organization who have participated in a 2-week initial training followed by 8-10 weeks of supervised practice. Counselors will receive weekly clinical supervision for the duration of the trial.
During the RCT, 10-12 weekly CETA sessions will be delivered individually in private spaces either at schools, homes, or in the community. In most cases, the children are living in the camps with their parents/guardians. Counselors will also follow-up with control children on a weekly basis to assess their symptoms using a client monitoring form. Both treatment and control participants will be reassessed using the same assessment instrument following the treatment period.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kachin
-
Myitkyina, Kachin, Myanmar, 101
- Kachin Baptist Convention Jan Mai Kawng Camp
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Moderately or severely affected (cutoff to be defined during validation phase) children ages 8-17 years.
Exclusion Criteria:
- Active psychosis or serious developmental disorder (e.g., mental retardation, autism) that would preclude participation in cognitive-behavioral oriented skills intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: CETA Treatment
For treatment group participants, they will then have weekly Common Elements Treatment Approach (CETA) counseling sessions with a counselor lasting no more than 1.5 hours per session, and a total of approximately 10-12 sessions.
They will then repeat the assessment instrument after their last session, as well as 6 months after finishing treatment, and these meetings will again last no more than 1.5 hours.
All total, it is expected that treatment group participants will have 13 meetings with a study team member or counselor over the course of their participation.
|
The Common Elements Treatment Approach (CETA), is a trans-diagnostic psychotherapy that is based on common evidence-based treatments for depression, anxiety, trauma and stress related disorders.
This treatment can be used to treat individuals with any of these mental health problems and with any combination of these problems.
CETA expands upon traditional treatment approaches that are designed to focus on one specific disorder and has been proven through multiple rigorous trials to reduce the burden of multiple common mental health problems and improve functionality among men and women living in low resource settings.
CETA can be provided to people in their own communities by trained and supervised lay providers, for example community health workers.
Other Names:
|
NO_INTERVENTION: Waitlist
Waitlist group participants be contacted by a study team member from the local partner organization regularly (weekly) while they are on the wait list.
These contacts from the study team will be short and last less than 30 minutes and will be used to briefly assess symptom levels and safety.
At the end of their wait period, they will be asked to complete the assessment instrument a second time and this meeting will take no more than 1.5 hours.
For participants in the waitlist group, we estimate 13 meetings total during their wait period (2 meetings of no more than 1.5 hours, 10 contacts less than 30 minutes).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in child mental health scores from composite measure
Time Frame: The time between pre- and post-test intervention assessment will be 8-12 weeks for treatment group (according to the number of CETA sessions) and 10 weeks for wait list participants.
|
Self-reported child mental health symptoms will be measured using a modified, locally validated version of the assessment instrument consisting of 23 items from 1) the Child PTSD Symptom Scale (CPSS); 2) and the Moods and Feelings Questionnaire (MFQ); and 3) items developed from qualitative research in this population.
Respondents report how often each problem has bothered him/her in the past two weeks.
Response options range from 0 "none of the time" to 3 "almost all of the time".
Results will be reported as a single value from this composite outcome measure consisting of multiple measures.
|
The time between pre- and post-test intervention assessment will be 8-12 weeks for treatment group (according to the number of CETA sessions) and 10 weeks for wait list participants.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in child behavior problem scores
Time Frame: The time between pre- and post-test intervention assessment will be 8-12 weeks for treatment group (according to the number of CETA sessions) and 10 weeks for wait list participants.
|
Self-reported child behavior problems will be assessed using a behavior problem checklist developed using qualitative data collected from this population.
Respondents report how often they have done or experienced each behavior in the past two weeks.
Response options range from 0 "none of the time" to 3 "almost all of the time".
|
The time between pre- and post-test intervention assessment will be 8-12 weeks for treatment group (according to the number of CETA sessions) and 10 weeks for wait list participants.
|
Change in child functional impairment
Time Frame: The time between pre- and post-test intervention assessment will be 8-12 weeks for treatment group (according to the number of CETA sessions) and 10 weeks for wait list participants.
|
Self-reported child functional impairment will be assessed using a functioning scale developed using qualitative data collected from this population.
Respondents report how much difficulty they currently have doing tasks of daily living.
Response options range from 0 "no difficulty" to 3 "often cannot do".
|
The time between pre- and post-test intervention assessment will be 8-12 weeks for treatment group (according to the number of CETA sessions) and 10 weeks for wait list participants.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Catherine Lee, PhD, Johns Hopkins Bloomberg School of Public Health
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00007317
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Child Mental Disorder
-
University Hospital, RouenRecruitingChild Development | Child Mental Disorder | Adolescent Behavior | Child Behavior Disorders | Behavior, Child | Adolescent Development | Adolescent - Emotional Problem | Child Development DisorderFrance
-
University of GlasgowUniversity of Nottingham; Queen Mary University of London; NSPCC; Glasgow City... and other collaboratorsRecruitingParent-Child Relations | Child Mental Disorder | Child MaltreatmentUnited Kingdom
-
McGill University Health Centre/Research Institute...Canadian Institutes of Health Research (CIHR); University of AlbertaActive, not recruitingParent-Child Relations | Autism Spectrum Disorder | Parenting | Mental Health Wellness 1 | Parent-child Problem | Child Development Disorder | Child Developmental DelayCanada
-
London School of Hygiene and Tropical MedicineInternational Centre for Diarrhoeal Disease Research, Bangladesh; University... and other collaboratorsActive, not recruitingChild Development | Child Development DisorderBangladesh, Tanzania, Nepal
-
O-KidiaRecruitingChild Development | Child Development DisorderFrance
-
General Administration of Military Health, TunisiaMilitary Hospital of TunisRecruiting
-
Assistance Publique - Hôpitaux de ParisUnknownAutism Spectrum Disorder | Child AutismFrance
-
King Abdulaziz UniversityCompleted
-
Stanford UniversityRecruitingChild Development | Developmental Disability | Autism | Behavior, Child | Behavior, Social | Autism Spectrum Disorder High-FunctioningUnited States
-
Assiut UniversityNot yet recruitingChild Mental Disorder | Child Behavior Disorders | Adolescent Behaviour DisorderEgypt
Clinical Trials on Common Elements Treatment Approach
-
International Rescue CommitteeJohns Hopkins University; Khon Kaen UniversityRecruitingEpilepsy | Hypertension | Diabetes | Medication Adherence | Self Efficacy | Mental Health IssueThailand
-
Johns Hopkins Bloomberg School of Public HealthNative American Research Centers for HealthActive, not recruiting
-
Michael J Mugavero, MDUniversity of North Carolina, Chapel HillCompletedDepression | HIV/AIDS | Anxiety | Substance Use Disorders | Post-traumatic Stress DisorderUnited States
-
Johns Hopkins Bloomberg School of Public HealthUnited States Agency for International Development (USAID)CompletedDepression | PostTraumatic Stress DisorderUkraine
-
Queen Mary University of LondonJohns Hopkins University; American University of Beirut Medical Center; Medical... and other collaboratorsCompletedDepression | PTSD | Anxiety | Conduct Disorder | Oppositional Defiant DisorderLebanon
-
Johns Hopkins Bloomberg School of Public HealthBurma Border ProjectsCompletedDepression | Anxiety | Posttraumatic StressThailand
-
Columbia UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); University of Alabama... and other collaboratorsTerminatedDepression | HIV/AIDS | Substance Use Disorders | Alcohol Use Disorder | Post-traumatic Stress DisorderZambia
-
Universidad del Valle, ColombiaJohns Hopkins Bloomberg School of Public Health; United States Agency for International... and other collaboratorsCompletedDepression | Anxiety | Post-Traumatic Stress Disorder | ViolenceColombia
-
University of Alabama at BirminghamRecruitingHiv | Alcohol ProblemUnited States
-
University of Alabama at BirminghamColumbia University; Centre for Infectious Disease Research in ZambiaRecruitingAlcohol-Related Disorders | HIV/AIDS | Mental IllnessZambia